HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A Natsume Selected Research
A Natsume Research Topics
Disease
9
Glioma (Gliomas)
10/2017 - 04/2000
7
Neoplasms (Cancer)
10/2017 - 11/2001
2
Glioblastoma (Glioblastoma Multiforme)
10/2015 - 04/2006
2
Medulloblastoma
11/2012 - 08/2007
1
Lung Neoplasms (Lung Cancer)
11/2012
1
Astrocytoma (Pilocytic Astrocytoma)
04/2006
1
Brain Neoplasms (Brain Tumor)
11/2001
1
Residual Neoplasm
04/2000
Drug/Important Bio-Agent (IBA)
4
Liposomes (Liposome)
IBA
11/2010 - 04/2000
3
Flucytosine (Ancobon)
FDA Link
11/2012 - 08/2007
2
Prodrugs
IBA
11/2012 - 05/2010
2
Cytosine Deaminase
IBA
11/2012 - 05/2010
2
Proteins (Proteins, Gene)
FDA Link
11/2010 - 04/2006
2
Interferon-beta
IBA
05/2010 - 04/2000
1
Long Noncoding RNA
IBA
10/2017
1
epidermal growth factor receptor VIII
IBA
10/2015
1
ErbB Receptors (EGF Receptor)
IBA
10/2015
1
Small Interfering RNA (siRNA)
IBA
11/2010
1
Alkylating Agents
IBA
11/2010
1
DNA (Deoxyribonucleic Acid)
IBA
11/2010
1
Temozolomide (Temodar)
FDA Link
Generic
11/2010
1
Methyltransferases
IBA
11/2010
1
Therapeutic Uses
IBA
11/2010
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
08/2007
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2006
1
Messenger RNA (mRNA)
IBA
04/2006
1
Angiogenesis Inhibitors
IBA
04/2006
1
1,2-dilauroylphosphatidylcholine
IBA
11/2001
1
didodecyl N- (alpha- trimethylammonioacetyl)glutamate
IBA
11/2001
1
dioleoyl phosphatidylethanolamine
IBA
11/2001
1
Unilamellar Liposomes
IBA
11/2001
1
trioctyl phosphine oxide (TOPO)
IBA
08/2000
1
Type II DNA Topoisomerases (Topoisomerase II)
IBA
08/2000
1
Antineoplastic Agents (Antineoplastics)
IBA
08/2000
1
Etoposide (VP 16)
FDA Link
Generic
08/2000
Therapy/Procedure
1
Aftercare (After-Treatment)
11/2012
1
Drug Therapy (Chemotherapy)
11/2010
1
Radiotherapy
11/2010
1
Therapeutics
11/2010
1
Immunotherapy
11/2001